Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 1.71 -3.39% -0.06
AMPE closed down 0.56 percent on Monday, September 27, 2021, on 57 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical AMPE trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength -3.39%
200 DMA Support Bullish -3.93%
Overbought Stochastic Strength -3.93%
Calm After Storm Range Contraction -4.47%
NR7 Range Contraction -4.47%
NR7-2 Range Contraction -4.47%
Stochastic Reached Overbought Strength -4.47%
Overbought Stochastic Strength -4.47%
Up 3 Days in a Row Strength -4.47%
Calm After Storm Range Contraction -1.72%
Older End-of-Day Signals for AMPE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 2 hours ago
200 DMA Support about 6 hours ago
Down 3% about 6 hours ago
Fell Below Previous Day's Low about 6 hours ago
Down 2 % about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ampio Pharmaceuticals, Inc. Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Clinical Development Eye Diabetes Autoimmune Diseases Inflammation Autoimmune Disease Healthcare Facilities Dysfunction Kidney Disease Diagnostic Products Kidney Diseases Macular Edema Diabetic Retinopathy Eye Disease Metabolic Disorders Diabetic Macular Edema Diabetic Nephropathy Eye Diseases Antioxidant Methylphenidate Inflammatory Conditions Inflammation Diseases Male Sexual Dysfunction Sexual Dysfunction

Is AMPE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.98
52 Week Low 0.7208
Average Volume 1,416,002
200-Day Moving Average 1.69
50-Day Moving Average 1.53
20-Day Moving Average 1.66
10-Day Moving Average 1.71
Average True Range 0.12
ADX 21.2
+DI 20.99
-DI 11.50
Chandelier Exit (Long, 3 ATRs) 1.46
Chandelier Exit (Short, 3 ATRs) 1.81
Upper Bollinger Bands 1.86
Lower Bollinger Band 1.46
Percent B (%b) 0.77
BandWidth 24.64
MACD Line 0.07
MACD Signal Line 0.05
MACD Histogram 0.014
Fundamentals Value
Market Cap 327.55 Million
Num Shares 185 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 126.43
Price-to-Sales 0.00
Price-to-Book 14.97
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.91
Resistance 3 (R3) 1.91 1.87 1.89
Resistance 2 (R2) 1.87 1.83 1.87 1.88
Resistance 1 (R1) 1.82 1.81 1.80 1.82 1.87
Pivot Point 1.77 1.77 1.76 1.77 1.77
Support 1 (S1) 1.72 1.74 1.70 1.72 1.67
Support 2 (S2) 1.68 1.71 1.68 1.66
Support 3 (S3) 1.63 1.68 1.65
Support 4 (S4) 1.63